Literature DB >> 33537938

Cannabinoids and Sleep/Wake Control.

Mónica Méndez-Díaz1, Alejandra E Ruiz-Contreras2, Jacqueline Cortés-Morelos3, Oscar Prospéro-García4.   

Abstract

The sleep-wake cycle is a complex process that includes wake (W), non-rapid-eye-movement (NREM) and rapid-eye-movement (REM) sleep. Each phase is regulated by specialized brain structures that, by means of different neurotransmitters, maintain the constant expression of the sleep-wake cycle. Molecules like orexin, serotonin, noradrenaline, histamine, for waking; GABA, adenosine, prostaglandins, for NREM sleep and acetylcholine and glutamate for REM sleep, among other molecules are responsible for the expression and maintenance of each phase. When the endocannabinoid system was being described for the first time, almost three decades ago, oleamide's sleep promoting properties were highlighted. Nowadays, enough evidence has been cumulated to support the endocannabinoid system role in the sleep-wake cycle regulation. The endocannabinoids oleamide anandamide, and 2-arachidonylglycerol promote NREM and/or REM sleep via the CB1R, thereby making this system a target to treat sleep disorders, such as insomnia.

Entities:  

Keywords:  2-arachidonylglycerol; Anadamide; Cannabinoid receptor 1; Insomnia; Non-rapid-eye-movement (NREM) sleep; Oleamide; Rapid-eye-movement (REM) sleep

Year:  2021        PMID: 33537938     DOI: 10.1007/978-3-030-61663-2_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  27 in total

Review 1.  Presynaptic LTP and LTD of excitatory and inhibitory synapses.

Authors:  Pablo E Castillo
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

Authors:  Lucía Callén; Estefanía Moreno; Pedro Barroso-Chinea; David Moreno-Delgado; Antoni Cortés; Josefa Mallol; Vicent Casadó; José Luis Lanciego; Rafael Franco; Carmen Lluis; Enric I Canela; Peter J McCormick
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

3.  Comorbidity of insomnia detected by the Pittsburgh sleep quality index with anxiety, depression and personality disorders.

Authors:  Hakan Atalay
Journal:  Isr J Psychiatry Relat Sci       Date:  2011       Impact factor: 0.481

4.  The effects of marijuana on human sleep patterns.

Authors:  E S Barratt; W Beaver; R White
Journal:  Biol Psychiatry       Date:  1974-02       Impact factor: 13.382

5.  A two process model of sleep regulation.

Authors:  A A Borbély
Journal:  Hum Neurobiol       Date:  1982

Review 6.  Endocannabinoid system dysfunction in mood and related disorders.

Authors:  C H Ashton; P B Moore
Journal:  Acta Psychiatr Scand       Date:  2011-03-09       Impact factor: 6.392

7.  Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459.

Authors:  Anushka V Goonawardena; Andrea Plano; Lianne Robinson; Ruth Ross; Iain Greig; Roger G Pertwee; Robert E Hampson; Bettina Platt; Gernot Riedel
Journal:  Behav Pharmacol       Date:  2015-04       Impact factor: 2.293

8.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

9.  From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors.

Authors:  Octavio Amancio-Belmont; Antonio Romano-López; Alejandra Evelin Ruiz-Contreras; Mónica Méndez-Díaz; Oscar Prospéro-García
Journal:  Dev Neurobiol       Date:  2017-01-26       Impact factor: 3.964

10.  Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys.

Authors:  C A Brown; M C Campbell; M Karimi; S D Tabbal; S K Loftin; L L Tian; S M Moerlein; J S Perlmutter
Journal:  Exp Neurol       Date:  2012-05-02       Impact factor: 5.330

View more
  2 in total

Review 1.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

Review 2.  The Endocannabinoid System as Prognostic Biomarker of the Obstructive Sleep Apnea Morbidity in COVID-19-Recovered Individuals.

Authors:  Eric Murillo-Rodríguez
Journal:  Sleep Vigil       Date:  2021-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.